(Circulation. 1999;100:1494-1498.)
© 1999 American Heart Association, Inc.
Brief Rapid Communications |
Expression of NADH/NADPH Oxidase p22phox in Human Coronary Arteries
From the First Department of Internal Medicine (N.I., S.T., Y.R., S.K., M.Y.) and the First Department of Pathology (H.A., Y.H., H.I.), Kobe University School of Medicine, Kobe, Japan.
Correspondence to Nobutaka Inoue, MD, PhD, 7-5-1 Kusunoki-cho, chuo-ku, Kobe 650-0017, Japan. E-mail nobutaka{at}med.kobe-u.ac.jp
Background—NADH/NADPH oxidase is an important source of superoxide in the vasculature. Recently, we found that polymorphism of the gene p22phox, a critical component of this oxidase, is associated with a risk of coronary artery disease. The aim of this study was to investigate the localization of p22phox in human coronary arteries and to examine its difference in expression between nonatherosclerotic and atherosclerotic coronary arteries.
Methods and Results—Using coronary artery sections from autopsied cases (n=11), the expression of p22phox was examined by immunohistochemistry and Western blotting. In nonatherosclerotic coronary arteries, p22phox was weakly expressed, mainly in the adventitia. In atherosclerotic coronary arteries, intensive immunoreactivity was detected in neointimal and medial smooth muscle cells and infiltrating macrophages in hypercellular regions and at the shoulder region. Semiquantitative analysis and Western blotting showed that the expression of p22phox in atherosclerotic coronary arteries was more pronounced than that in nonatherosclerotic arteries. Double staining revealed p22phox expression in adventitial fibroblasts, smooth muscle cells, macrophages in the neointima and media, and endothelial cells.
Conclusions—As atherosclerosis progressed, the expression of p22phox increased through the vessel wall. p22phox might participate in the pathogenesis and pathophysiology of atherosclerotic coronary disease.
Key Words: atherosclerosis • free radicals • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  M. Terashima, Y. Ohashi, H. Azumi, K. Otsui, H. Kaneda, K. Awano, S. Kobayashi, T. Honjo, T. Suzuki, K. Maeda, et al. Impact of NAD(P)H Oxidase-Derived Reactive Oxygen Species on Coronary Arterial Remodeling: A Comparative Intravascular Ultrasound and Histochemical Analysis of Atherosclerotic Lesions Circ Cardiovasc Interv, June 1, 2009; 2(3): 196 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Manea, S. A. Manea, A. V. Gafencu, M. Raicu, and M. Simionescu AP-1-Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 878 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arca, B. Conti, A. Montali, P. Pignatelli, F. Campagna, F. Barilla, G. Tanzilli, R. Verna, A. Vestri, C. Gaudio, et al. C242T Polymorphism of NADPH Oxidase p22phox and Recurrence of Cardiovascular Events in Coronary Artery Disease Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 752 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Han, H. Li, V. A. M. Villar, A. M. Pascua, M. I. Dajani, X. Wang, A. Natarajan, M. T. Quinn, R. A. Felder, P. A. Jose, et al. Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells Hypertension, February 1, 2008; 51(2): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das Role of the Adventitia in Pulmonary Vascular Remodeling Physiology, April 1, 2006; 21(2): 134 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ardanaz and P. J. Pagano Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang and X.-F. Ming Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res., March 1, 2006; 4(1): 53 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, J. Sadowski, B. Guzik, A. Jopek, B. Kapelak, P. Przybylowski, K. Wierzbicki, R. Korbut, D. G. Harrison, and K. M. Channon Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 333 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome Diabetes, January 1, 2006; 55(1): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Ginsburg, M. P. Donahue, and L. K. Newby Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1615 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ejiri, N. Inoue, S. Kobayashi, R. Shiraki, K. Otsui, T. Honjo, M. Takahashi, Y. Ohashi, S. Ichikawa, M. Terashima, et al. Possible Role of Brain-Derived Neurotrophic Factor in the Pathogenesis of Coronary Artery Disease Circulation, October 4, 2005; 112(14): 2114 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1452 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Dourron, G. M. Jacobson, J. L. Park, J. Liu, D. J. Reddy, M. L. Scheel, and P. J. Pagano Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H946 - H953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Sorescu, H. Song, S. L. Tressel, J. Hwang, S. Dikalov, D. A. Smith, N. L. Boyd, M. O. Platt, B. Lassegue, K. K. Griendling, et al. Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase Circ. Res., October 15, 2004; 95(8): 773 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, A. Ormsby, N. Oja-Tebbe, and P. J. Pagano Gene Transfer of NAD(P)H Oxidase Inhibitor to the Vascular Adventitia Attenuates Medial Smooth Muscle Hypertrophy Circ. Res., September 17, 2004; 95(6): 587 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yokoyama and N. Inoue How Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression are Regulated Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1540 - 1541. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, J. Sadowski, B. Kapelak, A. Jopek, P. Rudzinski, R. Pillai, R. Korbut, and K. M. Channon Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1614 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Murase, Y. Yamada, A. Hirashiki, S. Ichihara, H. Kanda, M. Watarai, F. Takatsu, T. Murohara, and M. Yokota Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women Eur. Heart J., June 1, 2004; 25(11): 970 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Wyche, S. S. Wang, K. K. Griendling, S. I. Dikalov, H. Austin, S. Rao, B. Fink, D. G. Harrison, and A. M. Zafari C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils Hypertension, June 1, 2004; 43(6): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Hasebe, Y. Aizawa, K. Izawa, J.-i. Kawabe, and K. Kikuchi Thermal Treatment Attenuates Neointimal Thickening With Enhanced Expression of Heat-Shock Protein 72 and Suppression of Oxidative Stress Circulation, April 13, 2004; 109(14): 1763 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishiyama, M. Yoshizumi, H. Hitomi, S. Kagami, S. Kondo, A. Miyatake, M. Fukunaga, T. Tamaki, H. Kiyomoto, M. Kohno, et al. The SOD Mimetic Tempol Ameliorates Glomerular Injury and Reduces Mitogen-Activated Protein Kinase Activity in Dahl Salt-Sensitive Rats J. Am. Soc. Nephrol., February 1, 2004; 15(2): 306 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. V Dantas, M. d. C. P Franco, M. M Silva-Antonialli, R. C.A Tostes, Z. B Fortes, D. Nigro, and M. H. C Carvalho Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase Cardiovasc Res, January 1, 2004; 61(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Chamseddine and F. J. Miller Jr. gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2284 - H2289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lassegue and R. E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kobayashi, N. Inoue, Y. Ohashi, M. Terashima, K. Matsui, T. Mori, H. Fujita, K. Awano, K. Kobayashi, H. Azumi, et al. Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability: Important Role of C-Reactive Protein Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1398 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Inoguchi, T. Sonta, H. Tsubouchi, T. Etoh, M. Kakimoto, N. Sonoda, N. Sato, N. Sekiguchi, K. Kobayashi, H. Sumimoto, et al. Protein Kinase C-Dependent Increase in Reactive Oxygen Species (ROS) Production in Vascular Tissues of Diabetes: Role of Vascular NAD(P)H Oxidase J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S227 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Azumi, K.-i. Hirata, T. Ishida, Y. Kojima, Y. Rikitake, S. Takeuchi, N. Inoue, S. Kawashima, Y. Hayashi, H. Itoh, et al. Immunohistochemical localization of endothelial cell-derived lipase in atherosclerotic human coronary arteries Cardiovasc Res, June 1, 2003; 58(3): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Spiekermann, U. Landmesser, S. Dikalov, M. Bredt, G. Gamez, H. Tatge, N. Reepschlager, B. Hornig, H. Drexler, and D. G. Harrison Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation Circulation, March 18, 2003; 107(10): 1383 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Landmesser and H. Drexler Oxidative stress, the renin-angiotensin system, and atherosclerosis Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A3 - A7. [Abstract] [PDF]
|
|
|
|
|
|
F. E. Rey and P. J. Pagano The Reactive Adventitia: Fibroblast Oxidase in Vascular Function Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1962 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kalinina, A. Agrotis, E. Tararak, Y. Antropova, P. Kanellakis, O. Ilyinskaya, M. T. Quinn, V. Smirnov, and A. Bobik Cytochrome b558-Dependent NAD(P)H Oxidase-Phox Units in Smooth Muscle and Macrophages of Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2037 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Rikitake, K.-i. Hirata, T. Yamashita, K. Iwai, S. Kobayashi, H. Itoh, M. Ozaki, J. Ejiri, M. Shiomi, N. Inoue, et al. Expression of G2A, a Receptor for Lysophosphatidylcholine, by Macrophages in Murine, Rabbit, and Human Atherosclerotic Plaques Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2049 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Channon Oxidative Stress and Coronary Plaque Stability Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1751 - 1752. [Full Text] [PDF]
|
|
|
|
|
|
H. Azumi, N. Inoue, Y. Ohashi, M. Terashima, T. Mori, H. Fujita, K. Awano, K. Kobayashi, K. Maeda, K. Hata, et al. Superoxide Generation in Directional Coronary Atherectomy Specimens of Patients With Angina Pectoris: Important Role of NAD(P)H Oxidase Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1838 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hamilton, M. J. Brosnan, S. Al-Benna, G. Berg, and A. F. Dominiczak NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels Hypertension, November 1, 2002; 40(5): 755 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christ, J. Bauersachs, C. Liebetrau, M. Heck, A. Gunther, and M. Wehling Glucose Increases Endothelial-Dependent Superoxide Formation in Coronary Arteries by NAD(P)H Oxidase Activation: Attenuation by the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Atorvastatin Diabetes, August 1, 2002; 51(8): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Van Heerebeek, C Meischl, W Stooker, C J L M Meijer, H W M Niessen, and D Roos NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol., August 1, 2002; 55(8): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Paravicini, L. M. Gulluyan, G. J. Dusting, and G. R. Drummond Increased NADPH Oxidase Activity, gp91phox Expression, and Endothelium-Dependent Vasorelaxation During Neointima Formation in Rabbits Circ. Res., July 12, 2002; 91(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M. T. Quinn, P. J. Pagano, and E. L. Schiffrin Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II Circ. Res., June 14, 2002; 90(11): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Itoh, S. Umemoto, M. Hiromoto, Y. Toma, Y. Tomochika, S. Aoyagi, M. Tanaka, T. Fujii, and M. Matsuzaki Importance of NAD(P)H Oxidase-Mediated Oxidative Stress and Contractile Type Smooth Muscle Myosin Heavy Chain SM2 at the Early Stage of Atherosclerosis Circulation, May 14, 2002; 105(19): 2288 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Kim, H. K. Shin, H. S. Lee, J. H. Lee, T. H. Lee, and K. W. Hong Gene transfer of Cu/Zn SOD to cerebral vessels prevents FPI-induced CBF autoregulatory dysfunction Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1836 - H1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hathaway, D. D. Heistad, D. J. Piegors, and F. J. Miller Jr Regression of Atherosclerosis in Monkeys Reduces Vascular Superoxide Levels Circ. Res., February 22, 2002; 90(3): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Silacci, A. Desgeorges, L. Mazzolai, C. Chambaz, and D. Hayoz Flow Pulsatility Is a Critical Determinant of Oxidative Stress in Endothelial Cells Hypertension, November 1, 2001; 38(5): 1162 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okuda, N. Inoue, H. Azumi, T. Seno, Y. Sumi, K.-i. Hirata, S. Kawashima, Y. Hayashi, H. Itoh, J. Yodoi, et al. Expression of Glutaredoxin in Human Coronary Arteries: Its Potential Role in Antioxidant Protection Against Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1483 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Husemann, A. Obstfeld, M. Febbraio, T. Kodama, and S. C. Silverstein CD11b/CD18 Mediates Production of Reactive Oxygen Species by Mouse and Human Macrophages Adherent to Matrixes Containing Oxidized LDL Arterioscler Thromb Vasc Biol, August 1, 2001; 21(8): 1301 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Lavigne, H. L. Malech, S. M. Holland, and T. L. Leto Genetic Demonstration of p47phox-Dependent Superoxide Anion Production in Murine Vascular Smooth Muscle Cells Circulation, July 3, 2001; 104(1): 79 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shi, R. Niculescu, D. Wang, S. Patel, K. L. Davenpeck, and A. Zalewski Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. Stokes, E. C. Clanton, J. M. Russell, C. R. Ross, and D. N. Granger NAD(P)H Oxidase-Derived Superoxide Mediates Hypercholesterolemia-Induced Leukocyte-Endothelial Cell Adhesion Circ. Res., March 16, 2001; 88(5): 499 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zalba, G. S. Jose, F. J. Beaumont, M. A. Fortuno, A. Fortuno, and J. Diez Polymorphisms and Promoter Overactivity of the p22phox Gene in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats Circ. Res., February 2, 2001; 88(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pagano NAD(P)H Oxidase: Marker of the Dedifferentiated Neointimal Smooth Muscle Cell? Arterioscler Thromb Vasc Biol, February 1, 2001; 21(2): 175 - 177. [Full Text] [PDF]
|
|
|
|
|
|
S. Kawashima, T. Yamashita, M. Ozaki, Y. Ohashi, H. Azumi, N. Inoue, K.-i. Hirata, Y. Hayashi, H. Itoh, and M. Yokoyama Endothelial NO Synthase Overexpression Inhibits Lesion Formation in Mouse Model of Vascular Remodeling Arterioscler Thromb Vasc Biol, February 1, 2001; 21(2): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Whitehead and G. A. FitzGerald Twenty-First Century Phox: Not Yet Ready for Widespread Screening Circulation, January 2, 2001; 103(1): 7 - 9. [Full Text] [PDF]
|
|
|
|
|
|
V. Schachinger, M.B. Britten, S. Dimmeler, and A.M. Zeiher NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function Eur. Heart J., January 1, 2001; 22(1): 96 - 101. [Abstract] [PDF]
|
|
|
|
 |
|
 V. J. Thannickal and B. L. Fanburg Reactive oxygen species in cell signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Öörni, M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res., November 1, 2000; 41(11): 1703 - 1714. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Guzik, N. E. J. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai, and K. M. Channon Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis Circulation, October 10, 2000; 102(15): 1744 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pagano Vascular gp91phox : Beyond the Endothelium Circ. Res., July 7, 2000; 87(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, N. E. J. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai, and K. M. Channon Vascular Superoxide Production by NAD(P)H Oxidase : Association With Endothelial Dysfunction and Clinical Risk Factors Circ. Res., May 12, 2000; 86 (9): e85 - e90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hsich, B. H. Segal, P. J. Pagano, F. E. Rey, B. Paigen, J. Deleonardis, R. F. Hoyt, S. M. Holland, and T. Finkel Vascular Effects Following Homozygous Disruption of p47phox : An Essential Component of NADPH Oxidase Circulation, March 21, 2000; 101(11): 1234 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Wolin How Could a Genetic Variant of the p22phox Component of NAD(P)H Oxidases Contribute to the Progression of Coronary Atherosclerosis? Circ. Res., March 3, 2000; 86(4): 365 - 366. [Full Text] [PDF]
|
|
|
|
|
|
C. Cahilly, C. M. Ballantyne, D.-S. Lim, A. Gotto, and A. J. Marian A Variant of p22phox, Involved in Generation of Reactive Oxygen Species in the Vessel Wall, Is Associated With Progression of Coronary Atherosclerosis Circ. Res., March 3, 2000; 86(4): 391 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hathaway, D. D. Heistad, D. J. Piegors, and F. J. Miller Jr Regression of Atherosclerosis in Monkeys Reduces Vascular Superoxide Levels Circ. Res., February 22, 2002; 90(3): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai, and K. M. Channon Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase Circulation, April 9, 2002; 105(14): 1656 - 1662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sorescu, D. Weiss, B. Lassegue, R. E. Clempus, K. Szocs, G. P. Sorescu, L. Valppu, M. T. Quinn, J. D. Lambeth, J. D. Vega, et al. Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis Circulation, March 26, 2002; 105(12): 1429 - 1435. [Abstract] [Full Text] [PDF]
|
|